Impact and use of prasugrel versus Clopidogrel as a function of age among patients with acute coronary syndrome undergoing percutaneous coronary intervention

Back

ESC Premium Access

Impact and use of prasugrel versus Clopidogrel as a function of age among patients with acute coronary syndrome undergoing percutaneous coronary intervention

Session: Poster session 6 - Antiplatelet therapy

Topic: Thrombosis and platelets

Speaker: Doctor J. Chandrasekhar (Melbourne, AU)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Jaya Chandrasekhar

Eastern Health, Melbourne (Australia)

0 follower

22 more presentations in this session

Comparison of the new oral P2Y12 inhibitor (Prasugrel/Ticagrelor) to Clopidogrel in type 2 diabetes mellitus patients with AMI

Speaker: Doctor M. Kim (Daejeon, KR)

Access

Abstract

Impact of antiplatelet drugs on cholesterol level of platelet lipid rafts

Speaker: Mrs V. Rabani (Besancon, FR)

Access

Abstract

Slides

Optical coherence tomography assessment of in-stent thrombus immediately after percutaneous coronary intervention in patients pretreatment with Prasugrel compared to Clopidogre

Speaker: Doctor Y. Katayama (Wakayama, JP)

Access

Abstract

Slides

Circadian variation of platelets inhibition with ticagrelor

Speaker: Doctor S. Fournier (Lausanne, CH)

Access

Abstract

Slides

Platelet reactivity is gender and age related

Speaker: Mr G. Vos (Nieuwegein, NL)

Access

Abstract

Slides

Access the full session

Poster session 6 - Antiplatelet therapy

Speakers: Doctor J. Chandrasekhar, Doctor M. Kim, Mrs V. Rabani, Doctor Y. Katayama, Doctor S. Fournier...

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources